Awardee OrganizationDIVISION OF BASIC SCIENCES - NCI
Description
Abstract Text
The TFIID components TAF7 and TAF1 regulate eukaryotic transcription initiation. TAF7 regulates transcription initiation of TAF1-dependent genes by binding to the acetyltransferase (AT) domain of TAF1 and inhibiting the enzymatic activity that is essential for transcription. TAF7 is released from the TAF1/TFIID complex upon completion of preinitiation complex assembly, allowing transcription to initiate. However, not all transcription is TAF1-dependent and the role of TAF7 in regulating TAF1-indepedent transcription has not been defined. The IFN-gamma--induced transcription factor CIITA is a coactivator and general transcription factor that regulates both MHC Class I and Class II gene transcription, and is thus critical to activated immune response. Known as the master regulator of Class II expression, CIITA is required for both Class II transcription and activated Class I expression. Its deficiency is linked to bare lymphocyte syndrome. Comparison of eukaryotic basal class I transcription and interferon-activated transcription initiation reveals similar preinitiation complex recruitment mechanisms, and striking parallels between their respective critical components, the TATA-binding protein (TBP)-associated factor 1 (TAF1) and CIITA. Both TAF1 and CIITA possess instrinsic acetyltransferase (AT) activity required to activate MHC transcription, which is regulated by TAF7. Moreover, CIITA can bypass the requirement for TAF1 to activate both the MHC class I and II promoters. TAF1 has two distinct kinase activities, located with its amino-terminal and carboxy-terminal domains. However, despite the striking functional parallels between CIITA and TAF1, no similar kinase activity has been reported for CIITA thus far. We have now identified the transcriptional coactivator CIITA as a novel atypical serine-threonine kinase whose substrates include various general transcription factors. We have characterized the kinase activity of the protein and mapped the putative kinase domains. We have proposed a model in which the kinase activity of CIITA serves a function similar to that of TAF1, in which it regulates TAF7 binding and release, and thus MHC transcription initiation. This may elucidate a novel role for CIITA in the regulation of activated transcription initiation and stimulated immune response during pathogenic infection.
Public Health Relevance Statement
Data not available.
NIH Spending Category
CancerGenetics
Project Terms
AcetyltransferaseAutoantigensAutoimmune DiseasesBare Lymphocyte SyndromesBindingBypassCell Surface ReceptorsComplexCritical PathwaysDataDiseaseEmployee StrikesFailureGeneral Transcription FactorsGenesGenetic TranscriptionGoalsHIVHormonesImmune responseImmunologic SurveillanceInfectionInflammationInterferon Type IIInterferonsLeadLinkMHC Class I GenesMHC Class II GenesMajor Histocompatibility ComplexMapsModelingMolecularPathway interactionsPeptidesPhosphotransferasesPlayProtein-Serine-Threonine KinasesProteinsRegulationRegulatory PathwayReportingResearchRoleSignal PathwaySignal TransductionStimulusTAF7 geneTATA-Binding Protein Associated FactorsTissuesTranscription CoactivatorTranscription InitiationTumor Antigensbasecarcinogenesiscytokineextracellularhuman TAF1 proteinneoplastic cellnovelpathogenprogramspromoterresponsetranscription factortumor
No Sub Projects information available for 1ZIABC009285-29
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1ZIABC009285-29
Patents
No Patents information available for 1ZIABC009285-29
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1ZIABC009285-29
Clinical Studies
No Clinical Studies information available for 1ZIABC009285-29
News and More
Related News Releases
No news release information available for 1ZIABC009285-29
History
No Historical information available for 1ZIABC009285-29
Similar Projects
No Similar Projects information available for 1ZIABC009285-29